Why the study?
Does propranolol preparation reduce FDG uptake in brown adipose tissue in omental and mesenteric regions during FDG PET/CT in a patient with malignant pheochromocytoma?
Does propranolol preparation reduce FDG uptake in brown adipose tissue in omental and mesenteric regions during FDG PET/CT in a patient with malignant pheochromocytoma?
Propranolol preparation can diminish intense FDG activity in brown adipose tissue in omental and mesenteric regions in patients with pheochromocytoma undergoing PET/CT.
Answers are grounded in this paper and cite their sources.
May support propranolol to reduce omental FDG uptake in pheochromocytoma PET/CT; hypothesis-generating from single case and needs confirmation.
A 39-year-old man who had a history of surgical excision of left adrenal pheochromocytoma 3 years ago underwent an FDG PET/CT scan to evaluate possible metastatic/recurrent disease. In addition to multiple FDG-avid lesions typical of hypermetabolic malignant disease and the FDG uptake in regions rich in brown adipose tissue, there was also intense FDG activity in the omental and mesenteric regions, which are not common locations of elevated FDG activity. On the repeat FDG PET/CT scan 3 days later after the patient was prepared with propranolol, the omental and mesenteric FDG activity was diminished.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: